Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 44 Glioma 16 Melanoma 11 Central Nervous System Neoplasms 11 Astrocytoma 11 Brain Neoplasms 10 Oligodendroglioma 7 Gliosarcoma 5 Small Cell Lung Carcinoma 4 Recurrence 3 Lymphoma 3 Leiomyosarcoma 3 Sarcoma 2 Neoplasms, Neuroepithelial 2 Neoplasms 2 Neoplasm Metastasis 2 Ependymoma 2 Diffuse Intrinsic Pontine Glioma 2 Breast Neoplasms 2 Uveal Melanoma 1 Seizures 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Extensive Stage Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pituitary Neoplasms 1

Interventions

Fluorouracil 80 Oxaliplatin 72 Leucovorin 66 Irinotecan 60 Capecitabine 58 Bevacizumab 57 Cetuximab 43 Folfox protocol 22 Drug Therapy 22 Neoadjuvant Therapy 19 HMPL-013 17 Colonoscopy 17 regorafenib 15 apatinib 11 Panitumumab 11 Chemotherapy, Adjuvant 11 trifluridine tipiracil drug combination 10 XELOX 10 Laparoscopy 10 IFL protocol 10 sintilimab 9 raltitrexed 9 Radiotherapy 9 Blood Specimen Collection 9 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 tislelizumab 7 pembrolizumab 7 Endoscopic Mucosal Resection 7 Aspirin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × Temozolomide × Clear all

NCT05031975 2022-09-02

ERASE-TMZ

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡